Jazz Pharmaceuticals, Inc. (JAZZ) Tops Q2 EPS by 4c

August 7, 2012 4:10 PM

Jazz Pharmaceuticals, Inc. (NASDAQ: JAZZ) reported Q2 EPS of $1.09 ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found